Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01041131 · ClinicalTrials.gov registry record

Laparoscopic Revision of Vertical Banded Gastroplasty to Gastric Bypass

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
70
Enrollment target

NCT01041131 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 70 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01041131 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
70 participants
Enrollment target

Study Summary

The main aim of this study is to analyze and report the intermediate term outcomes after laparoscopic revision Roux-en-Y gastric bypass (RYGB) surgery for failed and/or complicated Vertical Banded Gastroplasty (VBG). The foremost outcome measurements are 1) Fat loss mainly measured as weight loss and expressed as trends in BMI, %EWL, and/or %EBL. 2) Trend in Comorbidity status. 3) Subjective Satisfaction and Health-Related Quality of Life "HR-QoL" are measured by a standardized, non-validated satisfaction questionnaire and by a validated, disease-specific worldwide used HR-QoL questionnaire. 4) Morbidity \& Mortality include nutritional status and metabolic complications. Consequently, secondary objectives of this study are the following. 1) To assess failure rate defined as percentage of excess weight loss \< 50%, lowest BMI \>35 for morbidly obese (MO) or \>40 for superobese (SO), and/or lack of resolution/improvement of major comorbidities at the point in time when assessed at each postoperative year after the surgery under study. 2) To evaluate the metabolic and nutritional status by measurements of particular clinical and biochemical parameters.

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2009-10
Est. Completion 2009-12

What the Registry Record Tells You About NCT01041131

The ClinicalTrials.gov registry entry for NCT01041131 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01041131 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01041131 about?

NCT01041131 is a clinical study titled "Laparoscopic Revision of Vertical Banded Gastroplasty to Gastric Bypass". The main aim of this study is to analyze and report the intermediate term outcomes after laparoscopic revision Roux-en-Y gastric bypass (RYGB) surgery for failed and/or complicated Vertical Banded Gastroplasty (VBG). The foremost outcome measurements are 1) Fat loss mainly measured as weight loss an...

What is the current status of trial NCT01041131?

This trial is currently completed. The enrollment target is 70 participants. The study started on 2009-10. Estimated completion is 2009-12.

Who is sponsoring clinical trial NCT01041131?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.